MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy U.S. Food and Drug Administration (Press Release) 15:19 Mon, 09 Nov
US authorities launch investigation into Novartis gene therapy Zolgensma Swiss Info 09:52 Mon, 09 Nov
Novartis Confirms Nine Tumor Reports After Zolgensma Gene Therapy, With Two Showing Signs of Vector DNA Integration Medical Daily 15:48 Sat, 07 Nov
FDA Investigates Cancer Risk Associated With Novartis' Zolgensma Gene Therapy RTT News 12:50 Sat, 07 Nov
Sanofi rumoured to be eyeing high-profile Insmed takeover Pharmaceutical Technology 2h Sanofi Biotech Mergers and Acquisitions
FDA’s corrupt peptides policy endangers public health Public Citizen 1d FDA Public Citizen (US) Global Corruption
US authorities launch investigation into Novartis gene therapy Zolgensma Swiss Info 09:52 Mon, 09 Nov Zolgensma FDA Pharma All sources
Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more STAT 14:46 Fri, 06 Nov Pharma Biology UK Health
Bioartic's BrainTransporter collaboration with Novartis ends following program discontinuation RTT News 06:55 Tue, 03 Nov
Novel single domain antibody selectively binds oxytetracycline associated DNA aptamer News-Medical.Net 5h DNA Pharma Biotechnology
Anixa Biosciences Announces Issuance of Canadian Patent Strengthening International Protection for its Ovarian Cancer Vaccine Technology PR Newswire (Press Release) 1d Patent Law Intellectual Property Biotechnology
Atomvie global radiopharma and itm enter supply agreement for n.c.a. Lutetium-177 PR Newswire (Press Release) 1d Biotechnology